Australia develops breakthrough blood test for COVID-19 detection
Australia | News | 0 Comment | 21 Jul, 2020
The research team, led by Bioresource Processing Institute of Australia (BioPRIA) and Monash University’...Read more
Australian Government Injects $13.6m on Innovative Cancer Treatments trials
Australia | News | 1 Comment | 17 Jul, 2020
In early June 2020, Australia’s Department of Health offered $13.6 million to support 10 clinical trials rese...Read more
India discusses bilateral health co-operation with Australia
Australia | News | 0 Comment | 16 Jul, 2020
Dr. Harsh Vardhan, Union Minister for Health and Family Welfare, Government of India had a digital interaction with his ...Read more
Clinuvel launches second afamelanotide formulation
Australia | News | 0 Comment | 15 Jul, 2020
Australia based CLINUVEL Pharmaceuticals, has announced PRÉNUMBRA®, the Company’s second afamelanotide ...Read more
Luina Bio, XING to bring in fast SARS-CoV-2 diagnostic kit
Australia | News | 0 Comment | 14 Jul, 2020
Australia based Luina Bio is pleased to announce they have been selected to partner with XING Technologies (Brisbane) to...Read more
Carromex unveils leads for rapid drug analysis and discovery
Australia | News | 0 Comment | 13 Jul, 2020
Carromex, a mathematical research-based innovation company based in Australia, unveiled a new cloud-based pharmaceu...Read more
Avance Clinical Wins Frost & Sullivan “2020 Asia-Pacific CRO Market Leadership Award”
Australia | News | 0 Comment | 09 Jul, 2020
The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacifi...Read more
CSL Behring evaluates monoclonal Ab for respiratory distress
Australia | News | 0 Comment | 08 Jul, 2020
Australia based CSL Limited's part, CSL Behring has announced that the first patient has been enrolled in its ...Read more
Affinity discovers potent SARS-CoV-2 antibodies
Australia | News | 0 Comment | 03 Jul, 2020
Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for canc...Read more
Australia starts new projects to deal with drug resistance
Australia | News | 0 Comment | 02 Jul, 2020
Australia’s commitment to support the health and wellbeing of the Pacific Island neighbours remains steadfast, wit...Read more
Australia invests $19M in AI health research projects
Australia | News | 0 Comment | 01 Jul, 2020
The Australian Government is investing $19 million in transformative medical research projects using game-changing appli...Read more
Alterity meets US FDA for ATH434 pathway to treat Multiple System Atrophy
Australia | News | 0 Comment | 30 Jun, 2020
Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...Read more
Australia to study first interventional neuromodulation platform
Australia | News | 0 Comment | 29 Jun, 2020
US based Synchron Inc., a neurovascular bioelectronic medicine company, has announced that the University of Melbou...Read more
Neoteryx gets blood collection device registered in Australia
Australia | News | 0 Comment | 30 Jun, 2020
The Mitra® microsampling device from US company Neoteryx has been registered as a Class I in vitro diagnostic (IVD) ...Read more
Australia pitches $12M more for CVD research
Australia | News | 0 Comment | 26 Jun, 2020
The Australian government, together with the National Heart Foundation, is announcing a further $12 million for research...Read more
Australia invests over $5.7M in traumatic brain injury research
Australia | News | 0 Comment | 25 Jun, 2020
The Australian Government is investing over $5.7 million to further develop traumatic brain injury research, aimed at im...Read more
Cardiovascular disease (CVD) impact on Asia-Pacific markets
Australia | Analysis | 2 Comment | 23 Jun, 2020
HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...Read more
EIU launches APAC Economist Intelligence Unit report for heart ailments
Australia | News | 0 Comment | 23 Jun, 2020
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...Read more